-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Reviewing Arrayit (OTCMKTS:ARYC) & Cue Health (NASDAQ:HLTH)
Reviewing Arrayit (OTCMKTS:ARYC) & Cue Health (NASDAQ:HLTH)
Arrayit (OTCMKTS:ARYC – Get Rating) and Cue Health (NASDAQ:HLTH – Get Rating) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, institutional ownership, valuation, earnings and profitability.
Insider and Institutional Ownership
44.6% of Cue Health shares are held by institutional investors. 58.0% of Arrayit shares are held by insiders. Comparatively, 29.4% of Cue Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Get Arrayit alerts:Volatility & Risk
Arrayit has a beta of -0.48, meaning that its stock price is 148% less volatile than the S&P 500. Comparatively, Cue Health has a beta of 1.62, meaning that its stock price is 62% more volatile than the S&P 500.
Analyst Ratings
This is a summary of current ratings and price targets for Arrayit and Cue Health, as reported by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Arrayit | 0 | 0 | 0 | 0 | N/A |
Cue Health | 0 | 1 | 3 | 0 | 2.75 |
Cue Health has a consensus target price of $7.00, suggesting a potential upside of 248.26%.
Earnings and Valuation
This table compares Arrayit and Cue Health's revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Arrayit | N/A | N/A | N/A | N/A | N/A |
Cue Health | $522.06 million | 0.58 | $86.42 million | ($0.88) | -2.28 |
Cue Health has higher revenue and earnings than Arrayit.
Profitability
This table compares Arrayit and Cue Health's net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Arrayit | N/A | N/A | N/A |
Cue Health | -24.25% | -12.29% | -8.93% |
About Arrayit
(Get Rating)
Arrayit Corp. engages in developing, manufacturing and marketing life science tools and integrated systems for the analysis of genetic variation, biological function and diagnostics. Its products include microarrayers, Microarray Scanners, DNA Microarrays, Protein Microarrays, Microarray Printing, Microarray Substrate Slides, Microarray Instrument, Amplification & Labeling, purification kits, Microarray Tools, buffers and solutions, microarray Cleanrooms, Books & software, CGH Microarrays and Microarray Platforms. The company provides tools and services to genomic research centres, pharmaceutical companies, academic institutions, clinical research organizations, government agencies and biotechnology companies. Arrayit was founded by Todd J. Martinsky in November 1999 and is headquartered in Sunnyvale, CA.
About Cue Health
(Get Rating)
Cue Health Inc., a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, healthcare providers and payors, and public health agencies. The company offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, a solution that allows integrations with third-party applications and sensors. It also provides COVID-19 testing kits for the Cue Health Monitoring System The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California.
Receive News & Ratings for Arrayit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arrayit and related companies with MarketBeat.com's FREE daily email newsletter.
Arrayit (OTCMKTS:ARYC – Get Rating) and Cue Health (NASDAQ:HLTH – Get Rating) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, institutional ownership, valuation, earnings and profitability.
Arrayit(OTCMKTS: ARYC — 获取评级)和Cue Health(纳斯达克股票代码:HLTH — 获取评级)都是医疗公司,但哪只是优势股?我们将根据两家公司的风险强度、分析师建议、股息、机构所有权、估值、收益和盈利能力对比这两家公司。
Insider and Institutional Ownership
内部所有权和机构所有权
44.6% of Cue Health shares are held by institutional investors. 58.0% of Arrayit shares are held by insiders. Comparatively, 29.4% of Cue Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Cue Health的44.6%股票由机构投资者持有。58.0%的Arrayit股票由内部人士持有。相比之下,29.4%的Cue Health股票由内部人士持有。强大的机构所有权表明,对冲基金、捐赠基金和大型基金经理认为,从长远来看,股票的表现将超过市场。
Volatility & Risk
波动性与风险
Arrayit has a beta of -0.48, meaning that its stock price is 148% less volatile than the S&P 500. Comparatively, Cue Health has a beta of 1.62, meaning that its stock price is 62% more volatile than the S&P 500.
Arrayit的beta值为-0.48,这意味着其股价的波动性比标准普尔500指数低148%。相比之下,Cue Health的beta值为1.62,这意味着其股价的波动性比标准普尔500指数高62%。
Analyst Ratings
分析师评级
This is a summary of current ratings and price targets for Arrayit and Cue Health, as reported by MarketBeat.
据MarketBeat报道,这是Arrayit和Cue Health当前评级和目标价格的摘要。
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Arrayit | 0 | 0 | 0 | 0 | N/A |
Cue Health | 0 | 1 | 3 | 0 | 2.75 |
卖出评级 | 保持收视率 | 买入评级 | 强劲的买入评级 | 评分分数 | |
Arrayit | 0 | 0 | 0 | 0 | 不适用 |
提示健康 | 0 | 1 | 3 | 0 | 2.75 |
Cue Health has a consensus target price of $7.00, suggesting a potential upside of 248.26%.
Cue Health的共识目标价为7.00美元,这表明潜在的上涨空间为248.26%。
Earnings and Valuation
收益和估值
This table compares Arrayit and Cue Health's revenue, earnings per share and valuation.
该表比较了Arrayit和Cue Health的收入、每股收益和估值。
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Arrayit | N/A | N/A | N/A | N/A | N/A |
Cue Health | $522.06 million | 0.58 | $86.42 million | ($0.88) | -2.28 |
总收入 | 价格/销售比率 | 净收入 | 每股收益 | 市盈率 | |
Arrayit | 不适用 | 不适用 | 不适用 | 不适用 | 不适用 |
提示健康 | 5.2206 亿美元 | 0.58 | 8642 万美元 | (0.88 美元) | -2.28 |
Cue Health has higher revenue and earnings than Arrayit.
Cue Health 的收入和收益高于 Arrayit。
Profitability
盈利能力
This table compares Arrayit and Cue Health's net margins, return on equity and return on assets.
该表比较了Arrayit和Cue Health的净利润率、股本回报率和资产回报率。
Net Margins | Return on Equity | Return on Assets | |
Arrayit | N/A | N/A | N/A |
Cue Health | -24.25% | -12.29% | -8.93% |
净利润 | 股本回报率 | 资产回报率 | |
Arrayit | 不适用 | 不适用 | 不适用 |
提示健康 | -24.25% | -12.29% | -8.93% |
About Arrayit
关于 Arrayit
(Get Rating)
(获取评分)
Arrayit Corp. engages in developing, manufacturing and marketing life science tools and integrated systems for the analysis of genetic variation, biological function and diagnostics. Its products include microarrayers, Microarray Scanners, DNA Microarrays, Protein Microarrays, Microarray Printing, Microarray Substrate Slides, Microarray Instrument, Amplification & Labeling, purification kits, Microarray Tools, buffers and solutions, microarray Cleanrooms, Books & software, CGH Microarrays and Microarray Platforms. The company provides tools and services to genomic research centres, pharmaceutical companies, academic institutions, clinical research organizations, government agencies and biotechnology companies. Arrayit was founded by Todd J. Martinsky in November 1999 and is headquartered in Sunnyvale, CA.
Arrayit Corp. 从事开发、制造和销售用于分析遗传变异、生物学功能和诊断的生命科学工具和集成系统。其产品包括微阵列、微阵列扫描仪、DNA 微阵列、蛋白质微阵列、微阵列打印、微阵列基底幻灯片、微阵列仪器、扩增和标记、纯化套件、微阵列工具、缓冲器和解决方案、微阵列洁净室、书籍和软件、CGH 微阵列和微阵列平台。该公司为基因组研究中心、制药公司、学术机构、临床研究组织、政府机构和生物技术公司提供工具和服务。Arrayit 由 Todd J. Martinsky 于 1999 年 11 月创立,总部位于加利福尼亚州桑尼韦尔。
About Cue Health
关于 Cue Heal
(Get Rating)
(获取评分)
Cue Health Inc., a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, healthcare providers and payors, and public health agencies. The company offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, a solution that allows integrations with third-party applications and sensors. It also provides COVID-19 testing kits for the Cue Health Monitoring System The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California.
Cue Health Inc. 是一家医疗保健技术公司,为个人、企业、医疗保健提供者和付款人以及公共卫生机构设计和开发诊断测试平台。该公司提供包含硬件和软件组件的 Cue Integrated Care 平台,例如由 Cue Health Monitoring System(便携式可重复使用的阅读器 Cue Cartride)、样本收集棒 Cue Cartride 和样本收集棒 Cue Wand 组成;Cue Data and Integration Layer,一种具有基于云的数据和分析功能的解决方案;包括 Cue Health App 和 Cue Enterprise Dashboard 的 Cue Virtual Care 交付应用程序;以及允许与第三方集成的解决方案 Cue 生态系统集成和应用程序应用程序和传感器。它还为 Cue Health Monitoring System 提供 COVID-19 测试套件。该公司前身为 Cue Inc,并于 2017 年 12 月更名为 Cue Health Inc.Cue Health Inc. 成立于 2010 年,总部位于加利福尼亚州圣地亚哥。
Receive News & Ratings for Arrayit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arrayit and related companies with MarketBeat.com's FREE daily email newsletter.
每天接收 Arrayit 的新闻和评级 -在下面输入您的电子邮件地址,即可通过Marketbeat.com的免费每日电子邮件时事通讯接收Arrayit及相关公司的最新新闻和分析师评级的简明每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧